|
End-of-day quote
Wiener Boerse
21/08/2026
|
5-day change | 1st Jan Change | ||
| 59.60 EUR | -1.57% |
|
+3.47% | -5.85% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Chart: Technical Analysis
Stock exchange
Wiener Boerse
ROVI 59.60 €
-1.57%
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
BME
| ROVI | 59.80EUR | -0.17% | 4.5M € | |
CBOE
| ROVIe | 59.65EUR | -0.75% | 1.9M € | |
Mexican S.E.
| ROVI N | 1,168.82MXN | -2.76% | 877K $ | |
Tradegate
| 41L | 59.75EUR | -0.25% | 11.35K € | |
OTC Markets
| LABFF | 67.17USD | +1.98% | 8.06K $ | |
Berne S.E.
| 41L | 52.24CHF | +0.85% | 313.44 CHF | |
Boerse Muenchen
| 41L | 59.80EUR | -0.17% | 119.6 € | |
Deutsche Boerse AG
| 41L | 60.00EUR | +0.76% | 0 € | |
CBOE
| 0ILL | 60.82EUR | 0.00% | 0 € | |
Börse Stuttgart
| 41L | 59.65EUR | -0.33% | 0 € | |
Wiener Boerse
| ROVI | 59.60EUR | -1.57% | 0 € | |
Borsa Italiana
| 1ROVI | 60.25EUR | +3.61% | 0 € |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ROVI Stock
- ROVI Stock
- Charts Laboratorios Farmaceuticos Rovi, S.A.
Select your edition
All financial news and data tailored to specific country editions

















